Collegium Pharmaceutical Inc (COLL) is near the top in its industry group according to InvestorsObserver. COLL gets an overall rating of 62. That means it scores higher than 62 percent of stocks. Collegium Pharmaceutical Inc gets a 86 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 104 out of 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Collegium Pharmaceutical Inc Stock Today?
Collegium Pharmaceutical Inc (COLL) stock is lower by -4.99% while the S&P 500 has gained 1.42% as of 1:33 PM on Wednesday, Jan 20. COLL is down -$1.20 from the previous closing price of $24.06 on volume of 181,624 shares. Over the past year the S&P 500 has gained 16.02% while COLL has gained 6.03%. COLL earned $0.50 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 45.81.
Click Here to get the full Stock Score Report on Collegium Pharmaceutical Inc (COLL) Stock.
